Member Info for TC101

Not even the delisting from AIM to the Nasdaq? You know what, i've held LMT for so long, i'm going to keep them. Hopefully in 5 years, i'll look back and think it was a wise decision. T

I think its time to sell up on this now. I am very surprised they are doing a cash call again when they delist from AIM and join the Nasdaq. I thought we had enough funding to see us through until Aorfix made a decent return and puts LMT in a profitable position. i've made a bit of money on this when it jumped from 1p to 2p, however its time to bow out now and reinvest my funds from this into something that will actually make a healthy return in my lifetime. All the analysts say this is a buy at £2.50 however even if it did take off in the states it will take a while to get there. been with this stock since 2008. The only good news ever to come out was FDA approval which took ages. buy buy lmt, hope you do well. I'm going to be putting my funds from this into Lloy and MGM which have risen very nicely over the past 2 years.

I bought into these shares a long time ago (4 years), and i am starting to think that due to delays with FDA etc, the momentum has all gone now. Analyst have recommended a buy rating with a price target for approx £2.50ish. however and from what i have noticed, rarely is that achieved. Although this product is great, i really cannot see now a decent return on this product. So the question is should i stay or go? I do also think that existing non institutional investors like a number of us who thought we were going to make a killing will make a loss when and if this is delisted from LSE and on the Nasdaq.

I suspect as the main market for Aorfix is the USA, they are hoping that a number of American investors who i suspect prefer to trade in US dollars and in their timezone will pump money into the company. Advertising for medical products i again suspect is also higher in the US than the rest of the world so kind of makes sense to enlist with the Nasdaq. Agree with the way things are going finically and Japanese approval will also help. Just need the sales team to do their thing.

From my last post, the actual launch for Aorfix is happening this week at the Veith symposium in NYC. A standalone presentation is to be run over the coming days to annouce aorfix and go through evidence that suggest we have a top of the range product. Turn on the charm LMT, investors and physcians need influencing. GLA

Aorfix gets its official launch at the NY Veith symposium on the 29th Nov 2013. I hope to see this sp claim a little coming up or after the launch. Fingers crossed that physicians will take to this product.

Caught it this morning...phew. Reading the RNS, Japan approval should be a breeze considering we went through the hardest approval process there is. Then China and India. I do hope after Aorfix, they develop something new, but hey thats miles off. GLA

I do to believe we have the best product. Have invested in this since 2009. Its been a long journey but made easier as we have FDA approval. Hope the sales team turn on the charm, but hope that physicians recognise the USP of this product. Very proud that a UK based company receive FDA approval. Just read that a typical stent graft cost in the region of £5k....and that was back in 2009. Fingers crossed but am surprised about the timeframe. Approval was months ago so would have assumed they would have knocked on every hospital to promote Aorfix. The waiting continues

November is when they officially announce Aorfix. They are doing so at a symposium in NYC. You need to remember there are already established companies selling a similar type of product. So the price point for the device is key. Personally i dont expect to see any movement until they start to sell this thing (November) and we see the progress of sales.

http://www.bbc.co.uk/news/business-24117531 - UK Treasury sale of Lloyds Banking Group begins with big investors being offered 6% of partly state-owned bank The stake is valued at £3.3bn and after the sale the government will still own 32.7% of the bank

Aorfix US commercial launch underway, formal launch event at VEITH Symposium, November 2013

* now readily available

This SP wont move until they actually roll this out in the states. I know that a couple of patients in the US have already been treated. But from reading there annual results etc, they are going to formally announce Aorfix in q3 or in Q4. I am certain that i read they are going to a medical symposium in Nov to do this. So this SP in my opinion wont move until then. Its been a long hard road getting to this stage, and one would have thought that when the FDA approved the device and the new delivery system as well, LMT would have started promoting this device will great gusto. Well obviously they havent and we will have to wait for this symposium for the offical annoucment that Aorfix is not readily available in the US. When it is offically annouced then there Sales teams will have to go out there and do the do. Therefore i dopnt see this moving until next year. I do hope LMT give updates on Sales progress in the US, as this is the key market a number of us have been waiting for LMT to crack. Japan medical approval hopefully next year and i suspect it would be a breeze to get the device approved considering we have FDA approval. Then next step China...India etc. Now the question i have is how much does this device cost and what margin are LMT making. GLA

I personally dont expect this sp to move until LMT actually start selling this in America. Yes approval has happened, although from reading their RNS' they are planning to start selling this in H2 this year as they want to release it with a new delivery mechanism as well. Personally, when approval happened, i would have thought they woould want to move to the US asap....however appreciate it can take time. Just a waiting game now, and plus they have to compete against established players in this market.

Lots of sells recently! Either profit taking or someone knows something we dont. Surprising as LMT have approval now. Need to be quick and start getting thoses sales teams rolling in the orders! Strike whilst the iron is hot! Unless takeover is on a few peoples mind. Need to watch this closely!

Edison Investment Research values the shares at £3.46 since LMT got approval. I hope they are right!

Jange - Its great that you can cut and paste the RNS's .....but what are your opinions on the stock?? Well.....take over could happen so i think we need to keep an eye on that! Just need to see how they are going to penetrate the US marketing since approval was given!

Pursuant to the Second Subscription, the Concert Parties could acquire, in aggregate and assuming no take up under the Offer and that no Placees or Other Subscribers invest as part of the Second Subscription, up to 73.3 per cent. of the voting rights of the Company based on the minimum Second Issue Price, which without a waiver of the obligations under Rule 9 of the Code would require the Concert Parties to make a general offer under Rule 9 of the Code to acquire all of the New Ordinary Shares not already owned by them." - taken from a post on iii investor!

Time for many of us to take some profit!! Lets just wait and see how they are going to market and sell this device in the US. Should hear something soon!

About time! Confidence has been restored! Time for LMT to crack the whip and start selling this device to our friends across the pond. Japan approval for this should be far eaiser now considering the very strict processes they have. Then you can hit China then India! Just need to wait for them to generate the cash from the sales to see what the future has installed!